Cargando…
Systematic review of immunosuppressant guidelines in the COVID-19 pandemic
AIMS: Individuals taking immunosuppressants are at increased susceptibility to viral infections in general. However, due to the novel nature of the COVID-19, there is a lack of evidence about the specific risks of the disease in this patient group. This systematic review aims to summarize the curren...
Autores principales: | Barlow-Pay, Fenella, Htut, Thura Win, Khezrian, Mina, Myint, Phyo Kyaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882764/ https://www.ncbi.nlm.nih.gov/pubmed/33628418 http://dx.doi.org/10.1177/2042098620985687 |
Ejemplares similares
-
Acalabrutinib-Related Cardiac Toxicities in Patients with Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials
por: Htut, Thura Win, et al.
Publicado: (2021) -
Anticholinergic burden measures and older people’s falls risk: a
systematic prognostic review
por: Stewart, Carrie, et al.
Publicado: (2021) -
A Review of Frailty Syndrome and Its Physical, Cognitive and Emotional Domains in the Elderly
por: Khezrian, Mina, et al.
Publicado: (2017) -
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19
por: Myint, Phyo K., et al.
Publicado: (2021) -
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
por: Bruce, Eilidh, et al.
Publicado: (2020)